Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial

Published:2018-06 Issue:6 Volume:18 Page:615-626
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Smit Menno R,Ochomo Eric O,Aljayyoussi Ghaith,Kwambai Titus K,Abong'o Bernard O,Chen Tao,Bousema Teun,Slater Hannah C,Waterhouse David,Bayoh Nabie M,Gimnig John E,Samuels Aaron M,Desai Meghna R,Phillips-Howard Penelope A,Kariuki Simon K,Wang Duolao,Ward Steve A,ter Kuile Feiko O

Funder

Malaria Eradication Scientific Alliance

Bill & Melinda Gates Foundation

US Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference27 articles.

1. Ivermectin in human medicine, an overview of the current status of its clinical applications;González;Curr Pharm Biotechnol,2012

2. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination;Chaccour;Malar J,2013

3. Endectocides for malaria control;Foy;Trends Parasitol,2011